← Open Payments lookup

WILLIAM BYERS: Open Payments

NPI 1053736116 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,115 in 98 payments from 16 companies in 2025. Trend: 2023 $2,363 · 2024 $2,611 · 2025 $2,115

Food & beverage: $2,016Education: $100
CompanyPaymentsAmount
Axsome Therapeutics, Inc.15$272
Teva Pharmaceuticals USA, Inc.8$254
Vanda Pharmaceuticals Inc.11$241
ABBVIE INC.13$239
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$191
Lundbeck LLC6$190
E.R. Squibb & Sons, L.L.C.7$135
Takeda Pharmaceuticals U.S.A., Inc.5$126
Neurocrine BioSciences, Inc.5$112
Alkermes, Inc.3$79

Products named: REXULTI, FANAPT, VRAYLAR, Auvelity, CAPLYTA, AUSTEDO XR, COBENFY, TRINTELLIX.

Industry payments across FL — which companies pay providers there.